Literature DB >> 24257435

Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review.

João Santos-Antunes1, Cândida Abreu2, Fernando Magro3, Rosa Coelho4, Filipe Vilas-Boas4, Patrícia Andrade4, Susana Lopes4, Guilherme Macedo4.   

Abstract

Immunosuppressive treatments used in the management of Inflammatory Bowel Disease, namely steroids, thiopurines and anti-TNF drugs, raise the risk of acquiring opportunistic infections. However, most of these infections are mild and self-limited, not requiring specific therapy or suspension of the immunosuppressors. We report a case of disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under steroids and azathioprine.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Herpes Simplex Virus; Immunosuppression

Mesh:

Substances:

Year:  2013        PMID: 24257435     DOI: 10.1016/j.crohns.2013.10.011

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  3 in total

Review 1.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Disseminated Primary Herpes Simplex Virus Type 2 Infection in a 22-Year-Old male.

Authors:  Nathan Erdmann; Benjamin A Hewitt; Thomas Prescott Atkinson; Nicholas Van Wagoner
Journal:  Open Forum Infect Dis       Date:  2015-06-16       Impact factor: 3.835

Review 3.  Concomitant herpes simplex virus colitis and hepatitis in a man with ulcerative colitis: Case report and review of the literature.

Authors:  Varun K Phadke; Rachel J Friedman-Moraco; Brian C Quigley; Alton B Farris; J P Norvell
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.